Patents by Inventor Theodore Smith

Theodore Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030215948
    Abstract: Provided are adenoviral vectors and the production of such vectors. In particular, fiber shaft modifications for efficient targeting of adenoviral vectors are provided. The fiber shaft modifications can be combined with other modifications, such as fiber knob and/or penton modifications, to produce fully ablated (detargeted) adenoviral vectors. A scale-up method for the propagation of detargeted adenoviral vectors is also provided.
    Type: Application
    Filed: March 27, 2003
    Publication date: November 20, 2003
    Applicants: The Scripps Research Institute, Novartis AG
    Inventors: Michael Kaleko, Glen R. Nemerow, Theodore Smith, Susan C. Stevenson
  • Patent number: 6649375
    Abstract: An adenoviral vector including at least one DNA sequence encoding a clotting factor, such as, for example, Factor VIII, or Factor IX. Such vectors may be administered to a host in an amount effective to treat hemophilia in the host. The vectors infect hepatocytes very efficiently, whereby the hepatocytes express the DNA sequence encoding the clotting factor.
    Type: Grant
    Filed: September 10, 1998
    Date of Patent: November 18, 2003
    Assignee: Genetic Theraphy, Inc.
    Inventors: Sheila Connelly, Michael Kaleko, Theodore Smith
  • Publication number: 20020137213
    Abstract: This invention relates to mutated adenoviral fiber proteins and adenovirus particles containing such proteins. It further relates to polynucleotides encoding the proteins and vectors containing polynucleotides. It also relates to methods for making and using the adenoviral particles. With the mutated fiber proteins, the adenovirus particles no longer bind to their natural cellular receptor. They can then be “retargeted” to a specific cell type through the addition of a ligand to the virus capsid, which causes the virus to bind to and infect such cell. Specific fiber mutations are listed, which ablate binding to the natural receptor. Adenovirus particles with certain fiber mutations were found to enhance gene transfer to and expression in liver as compared to viral particles with wild-type fiber.
    Type: Application
    Filed: May 30, 2001
    Publication date: September 26, 2002
    Inventors: Paul L. Hallenbeck, Neeraja Idamakanti, John Leonard Jakubczak, Michael Kaleko, Michele Lynette Rollence, Theodore Smith, Susan C. Stevenson, David A. Stewart
  • Publication number: 20020132769
    Abstract: The present invention relates to targeting molecules which are useful to specifically target an adenoviral particle to a desired cell type. These targeting molecules comprise a soluble adenoviral receptor domain, a trimerization domain, and a targeting ligand domain. Further provided are polynucleotides encoding such targeting molecule, expression vectors including such polynucleotides, and methods to target an adenoviral particle to a cell, as well as methods to deliver a heterologous gene selectively to a cell.
    Type: Application
    Filed: October 5, 2001
    Publication date: September 19, 2002
    Inventors: Michael Kaleko, Jin Gwan Kim, Theodore Smith, Susan C. Stevenson
  • Publication number: 20020064812
    Abstract: An adenoviral vector including at least one DNA sequence encoding a clotting factor, such as, for example, Factor VIII, or Factor IX. Such vectors may be administered to a host in an amount effective to treat hemophilia in the host. The vectors infect hepatocytes very efficiently, whereby the hepatocytes express the DNA sequence encoding the clotting factor.
    Type: Application
    Filed: September 10, 1998
    Publication date: May 30, 2002
    Inventors: SHEILA CONNELLY, MICHAEL KALEKO, THEODORE SMITH
  • Patent number: 5935935
    Abstract: An adenoviral vector including at least one DNA sequence encoding a clotting factor, such as, for example, Factor VIII, or Factor IX. Such vectors may be administered to a host in an amount effective to treat hemophilia in the host. The vectors infect hepatocytes very efficiently, whereby the hepatocytes express the DNA sequence encoding the clotting factor.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 10, 1999
    Assignee: Genetic Therapy, Inc.
    Inventors: Sheila Connelly, Michael Kaleko, Theodore Smith
  • Patent number: 5265513
    Abstract: A sound enhancing insert for stringed instruments in general and for guitars, in particular. The insert is readily mountable between the string supporting bridge saddle and the string tie-down members without repair, alteration of, or replacement of instrument parts. One or more rigid members, constructed of metal, wood, rigid plastic or ceramic, are mounted with a top surface of the rigid member contacting a respective string and the bottom surface of the rigid member contacting the sound table of the instrument. The rigid members are preferably mounted within a pliant soft plastic material such as Neoprene for supporting the rigid members in place and making the insert adaptable to different string heights. The rigid members, in their engagement between string and sound table, provide a second reverberation signal, a change in sustain, and a change in timbre, depending upon the particular material used.
    Type: Grant
    Filed: March 9, 1992
    Date of Patent: November 30, 1993
    Inventor: Theodore A. Smith
  • Patent number: 4069177
    Abstract: Alkali metal carboxylate salts of starch-polyacrylonitrile graft copolymers produced by saponifying a starch-polyacrylonitrile graft copolymer are improved significantly by employment of step-wise grafting of the acrylonitrile, and by employment of starch which has been treated by one or more of the following steps, thinning, defatting, precooking.
    Type: Grant
    Filed: June 21, 1976
    Date of Patent: January 17, 1978
    Inventor: Theodore Smith
  • Patent number: D321700
    Type: Grant
    Filed: April 25, 1990
    Date of Patent: November 19, 1991
    Inventor: Theodore A. Smith